IL17A and prostate carcinoma: A key factor in the development of BPH is pro-inflammatory interleukin 17 (IL-17), secreted by Th17 lymphocytes, and is also involved in the development of colon cancer, breast cancer, lung cancer, pancreatic cancer and prostate cancer [12].